Skip to main content

KAER Biotherapeutics

October 18, 2023
Franciscan D
Company Description: Donovan B. Yeates, Ph.D., Founder and CEO, KAER Biotherapeutics Corporation is introducing a two new game-changing product line, AeroPulsR. This device enables aqueous liquid surfactant suspensions to be delivered as liquid aerosols at high concentrations to treat respiratory distress in pediatric and adult patients. Dr. Yeates was CEO of the incubator company, BioTechPlex Corporation. He was a Senior Research Career Scientist in the Department of Veterans Affairs and a Professor in the Departments of Bioengineering and Medicine at the University of Illinois at Chicago. He was a Section Chief in the Department of Medicine and Director of a university wide Occupation Health and Safety Center. Dr. Yeates is an emeritus professor with over 90 publications and 25 patents. He is a past president of the Chicago Thoracic Society and served on the board of directors of the Illinois Biotechnology Organization (IBIO). He has a Ph.D. in Medical Biophysics from the University of Toronto.
Donovan Yeates, CEO - KAER Biotherapeutics